Bruker (BRKR) Set to Announce Quarterly Earnings on Thursday

Bruker (NASDAQ:BRKR) is set to announce its earnings results before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.46 per share for the quarter. Bruker has set its FY24 guidance at $2.71-$2.76 EPS and its FY 2024 guidance at 2.710-2.760 EPS.Investors interested in listening to the company’s conference call can do so using this link.

Bruker (NASDAQ:BRKR) last posted its earnings results on Tuesday, February 13th. The medical research company reported $0.70 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.05. Bruker had a return on equity of 29.94% and a net margin of 14.41%. The company had revenue of $844.50 million for the quarter, compared to the consensus estimate of $809.35 million. During the same quarter in the previous year, the business earned $0.74 earnings per share. The company’s revenue for the quarter was up 19.2% on a year-over-year basis. On average, analysts expect Bruker to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Bruker Trading Down 3.1 %

NASDAQ:BRKR traded down $2.51 on Tuesday, reaching $78.75. The company’s stock had a trading volume of 367,812 shares, compared to its average volume of 800,027. Bruker has a 12-month low of $53.79 and a 12-month high of $94.86. The company has a quick ratio of 0.99, a current ratio of 1.80 and a debt-to-equity ratio of 0.83. The firm has a market cap of $11.45 billion, a price-to-earnings ratio of 27.83, a price-to-earnings-growth ratio of 2.05 and a beta of 1.17. The stock has a 50 day moving average price of $88.07 and a 200 day moving average price of $74.90.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were issued a $0.05 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.20 annualized dividend and a dividend yield of 0.25%. Bruker’s dividend payout ratio is presently 6.85%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. The Goldman Sachs Group boosted their price objective on Bruker from $66.00 to $74.00 and gave the company a “sell” rating in a report on Wednesday, April 10th. UBS Group boosted their target price on Bruker from $94.00 to $102.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. JPMorgan Chase & Co. raised Bruker from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $60.00 to $90.00 in a research note on Wednesday, February 14th. Citigroup boosted their target price on Bruker from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, February 14th. Finally, Stifel Nicolaus boosted their target price on Bruker from $63.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, February 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Bruker currently has a consensus rating of “Moderate Buy” and a consensus target price of $84.86.

Insider Activity

In other Bruker news, Director Hermann Fritz Requardt sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $90.06, for a total transaction of $1,350,900.00. Following the completion of the sale, the director now directly owns 23,147 shares of the company’s stock, valued at approximately $2,084,618.82. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 28.30% of the company’s stock.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.